Full Text View
Tabular View
No Study Results Posted
Related Studies
Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
This study has been completed.
Study NCT00119457   Information provided by TransTech Pharma

First Received on July 5, 2005.   Last Updated on June 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Venous Thromboembolism
Embolism and Thrombosis
Hip Fractures
Additional conditions recognized in this trial
Embolism
Fractures, Bone
Thromboembolism
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Femoral Fractures
Hip Injuries
Leg Injuries
Vascular Diseases
Wounds and Injuries
Interventions listed in this trial
TTP889
Additional drug interventions recognized in this trial
Fibrinolytic Agents
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
TransTech Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services